Adefovir
Showing 26 - 50 of 196
HBV Trial in Kaohsiung (Tenofovir Alafenamide Tablets)
Recruiting
- HBV
- Tenofovir Alafenamide Tablets
-
Kaohsiung, TaiwanKaohsiung Medical University Hospital
Dec 21, 2020
Parathyroid Hormone, Tenofovir Disoproxil Fumarate, Chronic Hepatitis, B Virus Without Hepatitis Delta (Diagnosis) Trial in
Not yet recruiting
- Parathyroid Hormone
- +3 more
- Ergocalciferol Capsules
- Calcium carbonate
-
Bangkok Noi, Bangkok, ThailandFaculty of Medicine Siriraj Hospital, Mahidol University
Mar 28, 2022
Renal Function of Patients With Chronic Hepatitis B in China
Unknown status
- Hepatitis B, Chronic
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-Sen University
Sep 3, 2020
Hepatitis B Trial in China (Tenofovir disoproxil fumarate (TDF) tablets, Adefovir dipivoxil (ADV) tablets)
Completed
- Hepatitis B
- Tenofovir disoproxil fumarate (TDF) tablets
- Adefovir dipivoxil (ADV) tablets
-
Guangzhou, Guangdong, China
- +19 more
Jun 13, 2018
Chronic Hepatitis B Trial in Singapore (stopping nucleos(t)ide therapy, Continue nucleos(t)ide analogue)
Unknown status
- Chronic Hepatitis B
- stopping nucleos(t)ide therapy
- Continue nucleos(t)ide analogue
-
Singapore, SingaporeNational University Hospital
Sep 24, 2019
Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB China
Completed
- Chronic Hepatitis B
-
Beijing, Beijing, China
- +54 more
Jul 13, 2020
Hepatitis B, Chronic Trial in Shatin, New Territories (Lamivudine, Adefovir dipivoxil, Fixed dose combination (Lamivudine and
Completed
- Hepatitis B, Chronic
- Lamivudine
- +2 more
-
Shatin, New Territories, Hong KongGSK Investigational Site
Aug 2, 2017
Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48 Trial (lamivudine plus
Unknown status
- Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48
- lamivudine plus adefovir combination
- Tenofovir Disoproxil Fumarate
- (no location specified)
Jul 28, 2017
Hepatitis B Trial run by the NIDDK (Tenofovir & Emtricitabine, Tenofovir)
Terminated
- Hepatitis B
- Tenofovir & Emtricitabine
- Tenofovir
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 23, 2019
Hepatitis B, Chronic, Chronic Kidney Diseases Trial in Hong Kong (Telbivudine)
Completed
- Hepatitis B, Chronic
- Chronic Kidney Diseases
-
Hong Kong, Hong KongDepartment of Medicine, The University of Hong Kong, Queen Mary
Dec 15, 2018
Nomogram Analysis for HBV Related Acute-on-chronic Liver Failure
Completed
- Liver Failure
- No special intervention was suitable for this observational study
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-sen University
Jan 2, 2020
HCC Patients After Curative Treatment With Low HBV Viral Load Trial in Kaohsiung, Taipei (Vemlidy® (Tenofovir Alafenamide; TAF),
Recruiting
- HCC Patients After Curative Treatment With Low HBV Viral Load
- Vemlidy® (Tenofovir Alafenamide; TAF)
- Placebo
-
Kaohsiung, State..., Taiwan
- +3 more
Jul 5, 2021
Hepatitis B, Chronic Trial in China (Tenofovir Alafenamide 25 MG)
Recruiting
- Hepatitis B, Chronic
- Tenofovir Alafenamide 25 MG
-
Bengbu, Anhui, China
- +9 more
Nov 15, 2020
Hepatitis B, Chronic Trial in Guangzhou (Telbivudine, Adefovir dipivoxil)
Completed
- Hepatitis B, Chronic
- Telbivudine, Adefovir dipivoxil
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-sen University
Oct 22, 2017
Chronic Hepatitis B Trial in Baltimore, Auckland (Selgantolimod, Placebo, Hepatitis B virus (HBV) OAV Therapy)
Entecavir for Decompensated HBV Cirrhosis
Completed
- Hepatitis B
- Liver Cirrhosis
-
Lucknow, UP, IndiaSanjay Gandhi Postgraduate Institute of Medical Sciences
Sep 23, 2019
Cirrhosis of Liver Due to Hepatitis B (Disorder) Trial in Guangzhou (pegylated interferon (Peg IFN)a-2b, Nucleoside
Recruiting
- Cirrhosis of Liver Due to Hepatitis B (Disorder)
- pegylated interferon (Peg IFN)α-2b
- Nucleoside (acid)analogue (NAs)
-
Guangzhou, Guangdong, ChinaThird Affliated Hospital of Sun Yat-sen University
Jun 19, 2019
Chronic Hepatitis B Trial in China (ePA-44, Placebo)
Completed
- Chronic Hepatitis B
- εPA-44
- Placebo
-
BeiJing, Beijing, China
- +14 more
Sep 17, 2019
Chronic Hepatitis b, Hepatic Carcinoma Trial in Shanghai (ETV;TDF;ADV, Peginterferon Alfa-2a)
Unknown status
- Chronic Hepatitis b
- Hepatic Carcinoma
- ETV;TDF;ADV
- Peginterferon Alfa-2a
-
Shanghai, ChinaHuashan Hospital
Sep 6, 2017
Post-operative HBV-related Hepatocellular Carcinoma
Terminated
- Hepatocellular Carcinoma
- Adefovir Dipivoxil and Lamivudine
-
Kaohsiung, Taiwan
- +7 more
Apr 26, 2017
Hepatitis B, Chronic Trial in Barcelona (Telbivudine, oral adefovir)
Completed
- Hepatitis B, Chronic
- Telbivudine
- oral adefovir
-
Barcelona, SpainNovartis Investigative Site
Mar 24, 2017
Difficult-to-treat CHB Patients:Comparison Between TDF
Completed
- The Difficult-to-treat Chronic Hepatitis B
-
Seoul, Korea, Republic ofDepartment of Internal Medicine, Yonsei University College of Me
Jul 15, 2018